Orlistat CAS: 96829-58-2
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Payment Terms
- MoneyGram,Western Union
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- dmaa, gbl, orlistat, 96829-58-2
- Category
- Pharmaceutical Intermediates
Simeiquan
- Verified Certificate
-
9
Product name | Orlistat CAS: 96829-58-2 | Certification | - |
---|---|---|---|
Category | Pharmaceutical Intermediates | Ingredients | - |
Keyword | dmaa , gbl , orlistat , 96829-58-2 | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | China | Stock | - |
Supply type | - | HS code | - |
Product Information
Orlistat
Product Name: Orlistat
Synonyms: (-)-Tetrahydrolipstatin(EquivalentToOrlistat);Orlipastat
CAS: 96829-58-2
MF: C29H53NO5
MW: 495.73
Appearance: White crystalline powder
Purity: 99.51%
Standard: USP
Use:An antiobesity agent. A pancreatic lipase inhibitor. Antiobesity agent. Orlistat is an pancreatic lipase inhibitor. Tetrahydrolipstatin (orlistat) is a semi-synthetic derivative of lipstatin, a metabolite isolated from Streptomyces toxytricini. Tetrahydrolipstatin is widely used for the treatment of obesity.
Orlistat COA:
Items | Standard | Results |
Description | White to kind of white powder | kind of white powder |
Melting point | 193.0-200 | 196.0-198.9 |
Water | 5-6.5% | 5.6% |
Solubility | Soluble in methanol | Complies |
PH | 4.0-6.0 | 5 |
Heavy Metals | <10ppm | Complies |
Assay | >96% | 99.2% |
Residue on ignition | <0.1% | 0.03% |
Single impurity | <0.2% | 0.19% |
Conclusion | Up to the Standard USP 32. |
Orlistat Description:
Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity. In most countries, it is sold under the trade name of Roche as a prescription drug and sold by GlaxoSmithKline in the UK and the United States. Its main function is to prevent the intake of fat in the body's diet as a lipase inhibitor, thereby reducing calorie intake. It applies to low-calorie diets that health care providers supervise.
Orlistat Application:
The effectiveness of orlistat in promoting weight loss is clear, albeit moderately. The pooled data from clinical trials show that people who give olivide have less than 2-3 kilograms (4.4-6.6 pounds) of medication than a year, except for changes in lifestyle such as diet and exercise. Is also a modest reduction in blood pressure, it seems to be able to prevent the onset of type 2 diabetes, whether due to weight loss itself or other effects; in a large randomized controlled trial, orlistat he was found in obese people will reduce the incidence of diabetes by nearly 40% Before Taking This Medicine
You should not take orlistat if you are allergic to it, or if you have:
gallbladder problems;
chronic malabsorption syndrome (an inability to absorb food and nutrients properly); or
if you are pregnant.
To make sure orlistat is safe for you, tell your doctor if you have:
liver disease;
kidney disease;
a history of gallstones or kidney stones;
underactive thyroid;
a history of pancreatitis;
type 1 or type 2 diabetes;
an eating disorder (anorexia or bulimia); or
if you take any other weight-loss medications (prescription or over-the-counter).
Orlistat Dosage:
1) Usual Adult Dose for Obesity:
120 mg orally three times a day with each main meal containing fat. The dose may be taken during the meal or within 1 hour of completing the meal.
Your daily intake of fat, carbohydrate and protein should be distributed over three meals. This means you will usually take one capsule at breakfast, one at lunch and another at dinner. To gain optimal benefit, avoid the intake of food containing fat between meals, such as biscuits, chocolate and savory snacks.
2) Usual Pediatric Dose for Obesity:
12 years or older:120 mg orally three times a day with each main meal containing fat.
The dose may be taken during the meal or within 1 hour of completing the meal.
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | MoneyGram,Western Union | Shipping time | Negotiable |
- President
- Jun Wu
- Address
- 25E Unit A, Meilongge, #2 New area Road, Minzhi Street, Longhua new area, Shenzhen, China
- Product Category
- Pharmaceutical Chemicals,Pharmaceutical Intermediates
- Year Established
- 2004
- No. of Total Employees
- 1-50
- Company introduction
-
Shenzhen Simeiquan Biotechnology Co., Ltd. is a subsidiary company of Wuhan Yuancheng Group, which located in Shenzhen. We are a leading Chinese chemical supplier special in fine chemical, flavor, food additive, pharmaceutical intermediates and steroid raw powders. Our main products are Cinnamic acid, Chloramphenicol, Tranexamic acid, Oryzanol, Griseofulvin, Benzocain, Lidocaine, Steroid raw powders etc. Our products are praised by customers from worldwide.
We advocate an enterprise idea that"Efficient innovation, integrity rigorous, friendship development, win-win cooperation. " On base of Survival by quality, Create profit by service, Building prestige by law and discipline, we have high sense of social responsibility and unique charming enterprise culture.
Since the establishment of the company, Simeiquan has employed many professionals with aptitude and possessed a team of marketing personnel with profound professional knowledge, excellent professional ability and rich experience. The company specialized in chemicals, pharmaceutical intermediate, flavor and fragrance, food additive etc, and has world-wide customers. It's perfect marketing network and Service Platform can sever the customers from 20 countries and distracts in domestic, Occident and southeast Asia timely. The company have gained the trust of the customers by it's wholehearted and professional service.
- Main Markets
-
Bahrain
Canada
Egypt
Hong Kong(China)
India
Indonesia
Iraq
Japan
Malaysia
U.S.A
- Main Product
Related Products
Limonin
3-amino-2-methylamino-5-(trifluoromethyl)pyridine
Cas 160149-03-1
Betamethasone 17-valerate
Phenylbutazone